Try it
PSM · Communicable diseases: leprosy reactions
Sample itemA 30-year-old man with lepromatous leprosy has been on multidrug therapy for 3 months. He now develops fever, malaise and crops of tender erythematous nodules over his limbs. What is the underlying mechanism of this reaction?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
B. Immune complex deposition (type III hypersensitivity) in erythema nodosum leprosum
Erythema nodosum leprosum is a type 2 lepra reaction seen mainly in lepromatous and borderline lepromatous disease, often after starting treatment as bacillary antigens are released. It is mediated by immune complexes and is treated with analgesics, corticosteroids or thalidomide, while multidrug therapy is continued. A type 1 reaction occurs in borderline disease with inflamed existing skin lesions and neuritis.
Option by option
A. Allergic reaction to rifampicin
A drug allergy would present with rash or fever early on, not typical crops of tender nodules in lepromatous leprosy.
B. Immune complex deposition (type III hypersensitivity) in erythema nodosum leprosum (correct)
Correct. ENL is a type III immune complex reaction.
C. Relapse due to rifampicin-resistant bacilli
Relapse would show new infiltrated lesions over time and is not a cause of acute reaction in the first months of therapy.
D. Delayed-type (type IV) hypersensitivity in a type 1 reaction
Delayed hypersensitivity underlies type 1 reactions, which show inflamed existing patches rather than new tender nodules.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More PSM questions
- BiostatisticsOf 200 people who truly have a disease, a screening test is positive in 180. What is the…
- Environmental healthAfter one hour of contact time, what residual free chlorine level is generally recommend…
- EpidemiologyWhich study design is the most efficient for investigating risk factors of a rare disease?
- BiostatisticsIn hypothesis testing, a Type I error is: